Skip to main content
Premium Trial:

Request an Annual Quote

OpGen, BGI Expand Collaboration

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OpGen said today that it is working with the Beijing Genomics Institute to expand their use of OpGen's optical mapping technology for de novo sequence finishing in human, plant, and animal genomes.

The company said it has already used its Optical Mapping Technology with BGI to complete a study based on human genome data to successfully close gaps in existing sequence folds.

The firm's Argus system and Maplt services deliver whole-genome genetic maps from single DNA molecules, and it provides whole-genome analysis for strain typing, comparative genomics, and sequence assembly of microbial genomes to the life sciences market

"Applying the complementary technologies, we can develop more representative reference genomes at much improved standard," BGI VP of R&D Xun Xu said in a statement.

"It will allow more accurate and specific genomics research for different groups of people. Furthermore, the potential in human metagenomics research by developing improved microbe assemblies will facilitate the application in human disease studies," Xu added.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.